According to the World Health Organization, more than 10% of the world’s death and disability is due to neurological disorders. The neurological field has a clinical need for innovations in reinforcement and reapproximation of dural tissue, bridging dural defects, adhesion prevention, and preventing cerebral fluid leakage. Medical device and biopharmaceutical companies are pursuing new and improved tools to help diagnose and treat these disorders. Increasingly, they are turning to the proven biomaterials and capabilities of DSM to help address these needs for advanced neurological treatment and repair.​